EarningsQ3 2024 Earnings Report

Mirum Pharmaceuticals (MIRM) Q3 2024 Earnings Report

0 Followers

MX:MIRM Q3 2024 EPS Results

Actual EPS-$5.39

Consensus EPS-$8.07

Beat/MissBeat by +$2.68

One Year Ago EPS-$10.24

Actual Revenue$1.62B

Expected Revenue$1.47B

Beat/MissBeat by +$150.58M

YoY Revenue Growth+89.37%

QuarterQ3 2024

Date11/12/2024

TimeBefore Open

Conference CallTuesday, November 12, 2024

MX:MIRM Upcoming Earnings

Mirum Pharmaceuticals's next earnings date is estimated for November 17, 2026, based on past reporting schedules.

MX:MIRM Q3 2024 Earnings Call

0:00 / 0:00

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 17, 2026	2026 (Q3)	-8.80 / -	0.898	―
Aug 05, 2026	2026 (Q2)	-13.35 / -19.04	-2.155	-783.33% (-16.88)
May 06, 2026	2026 (Q1)	-6.56 / -241.23	-5.389	-4376.67% (-235.85)
Feb 25, 2026	2025 (Q4)	1.01 / -1.80	-8.802	79.59% (+7.01)
Nov 04, 2025	2025 (Q3)	-2.51 / 0.90	-5.389	116.67% (+6.29)
Aug 06, 2025	2025 (Q2)	-5.86 / -2.16	-9.34	76.92% (+7.18)
May 07, 2025	2025 (Q1)	-5.93 / -5.39	-9.7	44.44% (+4.31)
Feb 26, 2025	2024 (Q4)	-4.63 / -8.80	-11.316	22.22% (+2.51)
Nov 12, 2024	2024 (Q3)	-8.07 / -5.39	-10.239	47.37% (+4.85)
Aug 07, 2024	2024 (Q2)	-8.48 / -9.34	-34.847	73.20% (+25.51)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed